Navigation Links
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia

formation, such as slit lamp exam or other appropriately sensitive methods, is recommended at initiation of treatment or shortly thereafter, and at 6-month intervals during chronic treatment.

The most commonly observed adverse events associated with the use of SEROQUEL monotherapy versus placebo in clinical trials for schizophrenia and bipolar disorder were dry mouth (9-44% vs 3-13%), sedation (30% vs 8%), somnolence (18-28% vs 7-8%), dizziness (11-18% vs 5-7%), constipation (8-10% vs 3-4%), SGPT increase (5% vs 1%), dyspepsia (5-7% vs 1-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The most commonly observed adverse events associated with the use of SEROQUEL versus placebo in clinical trials as adjunct therapy with lithium or divalproex in bipolar mania were somnolence (34% vs 9%), dry mouth (19% vs 3%), asthenia (10% vs 4%), constipation (10% vs 5%), abdominal pain (7% vs 3%), postural hypotension (7% vs 2%), pharyngitis (6% vs 3%), and weight gain (6% vs 3%).

Please see the full Prescribing Information including Boxed Warnings for SEROQUEL available at http://www.seroquel.com .

About Schizophrenia

Schizophrenia is a serious brain disorder with symptoms including distorted perceptions of reality, hallucinations and delusions, illogical thinking, and flat or blunted emotions.(4) Schizophrenia affects men and women with equal frequency, but the first signs of schizophrenia typically emerge earlier in men (in late teens or early twenties) compared to women (in twenties or early thirties).(5) Over 2 million American adults -- about 1 percent of the population age 18 and older -- suffer from schizophrenia. Medications are important in the management of symptoms. While there is no cure for schizophrenia, it is a highly treatable and manageable illness. Medications are classified into two categories -- "conventional" and "atypical" antipsychotics.(6)

About AstraZeneca


'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:10/17/2014)... 2014   DaVita HealthCare Partners Inc. ... nation,s largest and most innovative health care communities, ... the company,s award-winning, leadership development and cultural orientation ... from around the globe were in attendance for ... is a two-day one-of-a-kind experience for new and ...
(Date:10/16/2014)... SUNNYVALE, Calif., Oct. 16, 2014  Cepheid (Nasdaq: ... quarter of 2014 of $115.2 million, representing growth of ... 2013.  Net loss in the third quarter of 2014 ... to net loss of $(1.4) million, or $(0.02) per ... Excluding stock-based compensation expense, amortization of debt discount ...
(Date:10/16/2014)... Oct. 16, 2014 Eight finalists, all representing ... to present their proposals for a chance to compete ... Sheikh Zayed Institute Second Annual Pediatric Surgical Innovation ... on Friday, Oct. 24, 2014. Selected ... across the US and internationally, the finalists are: ...
Breaking Medicine Technology:DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3Cepheid Reports 2014 Third Quarter Results 2Cepheid Reports 2014 Third Quarter Results 3Cepheid Reports 2014 Third Quarter Results 4Cepheid Reports 2014 Third Quarter Results 5Cepheid Reports 2014 Third Quarter Results 6Cepheid Reports 2014 Third Quarter Results 7Cepheid Reports 2014 Third Quarter Results 8Cepheid Reports 2014 Third Quarter Results 9Cepheid Reports 2014 Third Quarter Results 10Cepheid Reports 2014 Third Quarter Results 11Cepheid Reports 2014 Third Quarter Results 12Cepheid Reports 2014 Third Quarter Results 13Cepheid Reports 2014 Third Quarter Results 14Cepheid Reports 2014 Third Quarter Results 15Cepheid Reports 2014 Third Quarter Results 16Cepheid Reports 2014 Third Quarter Results 17Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4
... Biocept, Inc. ("Biocept"), an emerging leader in rare cell ... has issued a patent for Biocept,s cell separation technology using ... Separation and Analysis and Method of Using" protects Biocept,s microflow ... flow path where straight-line flow is interrupted by transverse posts ...
... FRANKLIN LAKES, N.J. , May 20 David B. Snow Jr. , ... to address the 2010 Citi Investment Research Global Health Care Conference in New York ... , The presentation at the ... , Medco,s chief financial officer, is also scheduled to attend. , ...
Cached Medicine Technology:Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology 2Medco to Present at the 2010 Citi Investment Research Global Health Care Conference 2
(Date:10/20/2014)... (PRWEB) October 20, 2014 Rockynol ... Living Center on Oct. 14. The $11 million project ... services, and a cooked-to-order kitchen with full-service restaurant style ... premier choice for first class Assisted Living apartments,” said ... residents deserve the highest quality of care and this ...
(Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 National ... Ohio Chapter of the American Academy of Pediatrics (Ohio AAP, ... Administration (NHTSA) in encouraging parents of teen drivers to talk ... hit the road. , Motor vehicle crashes are the leading ... 2,055 teen drivers involved in fatal crashes, and 859 (42%) ...
(Date:10/20/2014)... It’s hard to imagine what it’s like to ... around the world, it’s a reality. And while new shoes ... forced to walk barefoot on rocky terrain or sewage-lined streets ... their friends. , Buckner International's Shoes for Orphan ... in October to encourage support for Air1 and while also ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... 2014 Recently, BambooIndustry.com, one of the ... new range of bamboo deckings . Moreover, the ... items; they are now available at deeply discounted rates. ... is hard to overstate the significance of online business ... online services. The company’s workers are striving to deliver ...
Breaking Medicine News(10 mins):Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2
... Rutgers University have uncovered a new way to stimulate ... tumor cell clearance. Dipak Sarkar, professor in the ... Environmental and Biological Sciences and his research team have ... activate the immune cells to prevent cancer growth through ...
... , COLLEGE PARK, Md. - Revenue-driven surgery and poor ... a pair of logistical studies conducted by researchers at ... Business. The studies show a correlation between readmission ... time of discharge, suggesting that patients went home before ...
... a form of cancer where the plasma cells in the ... as well as predisposing patients to anemia, infection and kidney ... transplantation, commonly known as a stem cell transplant, is frequently ... Unfortunately, multiple myeloma continues to progress even after a transplant. ...
... Women who,ve witnessed or been the victims of violence may ... to new research. The study included 481 women being ... for a history of violence and current sexual risk-taking behaviors, ... unprotected sex. The researchers categorized the women as those ...
... -- ,Regions of the United States with lots of hospital ... have higher hospital readmission rates than regions with fewer beds ... Factors related to supply and demand had more of an ... or the quality of care received by patients the first ...
... Chicago Stritch School of Medicine student Jason Cuomo has ... Prize for Excellence in Neurology. The award recognizes excellence ... selected Cuomo to receive the prize, which is awarded ... The award is given to a student who exemplifies ...
Cached Medicine News:Health News:Rutgers team discovers novel approach to stimulate immune cells 2Health News:Rutgers team discovers novel approach to stimulate immune cells 3Health News:Revenue-driven surgery drives patients home too early 2Health News:Revenue-driven surgery drives patients home too early 3Health News:Study shows benefit of new maintenance therapy for multiple myeloma 2Health News: Women Exposed to Violence Might Have More Risky Sex 2Health News:Availability of Beds, Poverty Drive Costly Hospital Readmissions 2Health News:Availability of Beds, Poverty Drive Costly Hospital Readmissions 3
... the future with the all-new EXAM-3000! ... efficiency, dramatically increase your patient flow ... and money. Todays demand for delegation ... the logical choice for the progressive ...
... For those who need to move their imaging ... handy portable solution. The IMAGEnet Portable System features ... flat panel monitor. This portable PC solution can ... choices to be tailored to your multi-site imaging ...
... Based on the latest digital chip ... FA/Color System from Topcon features 3,072 x ... range for each color channel! The system ... also features real-time image acquisition, which facilitates ...
... Viewer, with its dual magnification and ... precise, convenient, and efficient than ever ... or endothelial cell count photos to ... your ophthalmic needs, without the inherent ...
Medicine Products: